Test catalogue
Molecular oncology testing for targeted therapy.
Biomarkers that guide treatment from a tumour block: EGFR in lung cancer, KRAS, NRAS and BRAF in colorectal cancer and melanoma, MSI and MLH1 methylation, MGMT in glioblastoma, NTRK fusions, and BRCA1/2 founder variants.
8 tests
- EGFR exons 18–21Non-small cell lung cancer→
- KRAS / NRASColorectal cancer→
- BRAF codon 600Melanoma, colorectal and thyroid cancer→
- MSIMicrosatellite instability→
- MLH1 promoterLynch syndrome work-up→
- MGMT promoterGlioblastoma→
- NTRK fusionsSolid tumours, targeted therapy→
- BRCA1 / BRCA2Hereditary breast and ovarian cancer→
Request this test
Offer this test to your patients.
Contract pricing and turnaround times are provided on request for laboratories and clinics.
- Inherited disordersThalassemia, SMA, CF & FMF Genetic Testing for Hospitals→
- Reproductive & neurogeneticsFragile X, Y-AZF, QF-PCR & Repeat Expansion Testing→
- Immunogenetics & thrombophiliaHLA-B27, HLA-B51, Coeliac HLA & Factor V Leiden Testing→
- Haematological malignanciesBCR-ABL1, JAK2, CALR, FLT3 & NPM1 Leukaemia Testing→
- Extended panels (on request)Thrombophilia Panel, MTHFR & PAI-1 Genetic Testing→